Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 6
2004 2
2005 9
2006 2
2007 1
2008 4
2009 4
2010 4
2011 4
2012 5
2013 10
2014 5
2015 6
2016 4
2017 1
2018 2
2019 4
2020 6
2021 7
2022 7
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Bispecific Immunomodulatory Antibodies for Cancer Immunotherapy.
Blanco B, Domínguez-Alonso C, Alvarez-Vallina L. Blanco B, et al. Among authors: alvarez vallina l. Clin Cancer Res. 2021 Oct 15;27(20):5457-5464. doi: 10.1158/1078-0432.CCR-20-3770. Epub 2021 Jun 9. Clin Cancer Res. 2021. PMID: 34108185 Free PMC article. Review.
Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer.
Tapia-Galisteo A, Sánchez Rodríguez Í, Aguilar-Sopeña O, Harwood SL, Narbona J, Ferreras Gutierrez M, Navarro R, Martín-García L, Corbacho C, Compte M, Lacadena J, Blanco FJ, Chames P, Roda-Navarro P, Álvarez-Vallina L, Sanz L. Tapia-Galisteo A, et al. Among authors: alvarez vallina l. Oncoimmunology. 2022 Feb 7;11(1):2034355. doi: 10.1080/2162402X.2022.2034355. eCollection 2022. Oncoimmunology. 2022. PMID: 35154908 Free PMC article.
Applications of trimerbodies in cancer immunotherapy.
Compte M, Sanz L, Álvarez-Vallina L. Compte M, et al. Among authors: alvarez vallina l. Int Rev Cell Mol Biol. 2022;369:71-87. doi: 10.1016/bs.ircmb.2022.03.008. Epub 2022 May 16. Int Rev Cell Mol Biol. 2022. PMID: 35777865
Engineered mRNA and the Rise of Next-Generation Antibodies.
Sanz L, Álvarez-Vallina L. Sanz L, et al. Among authors: alvarez vallina l. Antibodies (Basel). 2021 Sep 26;10(4):37. doi: 10.3390/antib10040037. Antibodies (Basel). 2021. PMID: 34698057 Free PMC article. Review.
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response.
Rubio-Pérez L, Lázaro-Gorines R, Harwood SL, Compte M, Navarro R, Tapia-Galisteo A, Bonet J, Blanco B, Lykkemark S, Ramírez-Fernández Á, Ferreras-Gutiérrez M, Domínguez-Alonso C, Díez-Alonso L, Segura-Tudela A, Hangiu O, Erce-Llamazares A, Blanco FJ, Santos C, Rodríguez-Peralto JL, Sanz L, Álvarez-Vallina L. Rubio-Pérez L, et al. Among authors: alvarez vallina l. Oncoimmunology. 2023 Apr 24;12(1):2205336. doi: 10.1080/2162402X.2023.2205336. eCollection 2023. Oncoimmunology. 2023. PMID: 37114242 Free PMC article.
Efficient preclinical treatment of cortical T cell acute lymphoblastic leukemia with T lymphocytes secreting anti-CD1a T cell engagers.
Jiménez-Reinoso A, Tirado N, Martinez-Moreno A, Díaz VM, García-Peydró M, Hangiu O, Díez-Alonso L, Albitre Á, Penela P, Toribio ML, Menéndez P, Álvarez-Vallina L, Sánchez Martínez D. Jiménez-Reinoso A, et al. Among authors: alvarez vallina l. J Immunother Cancer. 2022 Dec;10(12):e005333. doi: 10.1136/jitc-2022-005333. J Immunother Cancer. 2022. PMID: 36564128 Free PMC article.
The coming of age of engineered multivalent antibodies.
Nuñez-Prado N, Compte M, Harwood S, Álvarez-Méndez A, Lykkemark S, Sanz L, Álvarez-Vallina L. Nuñez-Prado N, et al. Among authors: alvarez vallina l. Drug Discov Today. 2015 May;20(5):588-94. doi: 10.1016/j.drudis.2015.02.013. Epub 2015 Mar 7. Drug Discov Today. 2015. PMID: 25757598 Review.
90 results